作者
Edoardo Del Poggetto,I-Lin Ho,Chiara Balestrieri,Er-Yen Yen,Shaojun Zhang,Francesca Citron,Rutvi Shah,Denise Corti,Giuseppe R. Diaferia,Chieh-Yuan Li,Sara Loponte,Federica Carbone,Yoku Hayakawa,Giovanni Valenti,Shan Jiang,Luigi Sapio,Hong Jiang,Prasenjit Dey,Sisi Gao,Angela K. Deem,Stefan Rose‐John,Wantong Yao,Haoqiang Ying,Andrew D. Rhim,Giannicola Genovese,Timothy P. Heffernan,Anirban Maitra,Timothy C. Wang,Linghua Wang,Giulio Draetta,Alessandro Carugo,Gioacchino Natoli,Andrea Viale
摘要
Defining tumor cell immune evasion Mouse models used to study cancer often lack a full immune system, allowing implantation of human tumors into the mice. By contrast, naturally evolving tumors must contend with a fully functional immune system and its destruction of some of the cells (see the Perspective by Ho and Wood). Two groups now report studies on mouse models with a fully intact immune system. Martin et al . started with preexisting murine tumor cell lines and examined their continued evolution in vivo, whereas Del Poggetto et al . examined the development of new pancreatic tumors in the context of inflammation, as is often seen in human patients. In each study, the authors found that the immune system exerted a selective pressure on cells that would give rise to tumors, promoting the survival of those that had lost expression of tumor suppressor genes or activated a specific oncogene. The findings suggest a major role for the immune system in driving tumor evolution across multiple types of cancer. —YN